Schedule of Segment Reporting Information, by Segment |
There are no differences from the Company’s 2024 Form 10-K in the factors used to identify the reportable segments or measurement basis for segment loss. Significant segment expenses, as provided to the CODM, are presented below (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | Research and development payroll-related costs | $ | 5,089 | | | $ | 4,253 | | | $ | 10,321 | | | $ | 7,281 | | General and administrative payroll-related costs | 2,003 | | | 1,750 | | | 4,156 | | | 3,299 | | Clinical trial expenses | 6,023 | | | 3,043 | | | 12,032 | | | 5,238 | | Chemistry, manufacturing, and controls costs | 3,124 | | | 5,842 | | | 7,470 | | | 10,235 | | Medical affairs expenses | 977 | | | 657 | | | 1,532 | | | 944 | | Research and development consulting expenses | 1,537 | | | 948 | | | 2,910 | | | 1,779 | | General and administrative consulting expenses | 1,302 | | | 1,605 | | | 2,338 | | | 3,595 | | Other segment items1 | 3,037 | | | (611) | | | 5,303 | | | (1,573) | | Segment and consolidated net loss | $ | 23,092 | | | $ | 17,487 | | | $ | 46,062 | | | $ | 30,798 | |
1Other segment items include legal expenses, accounting expenses, IT and facilities expenses, insurance expenses, other operating expenses, interest income, investment income, stock-based compensation expense, depreciation expense, and other income, net.
|